Jefferies & Co. raised its price target on Medco Health Solutions Inc. MHS to $67 from $65, and has a Buy rating on shares.
Jefferies writes in the research note, "MHS rallied after mgmt's FY11 guidance, which encompassed the Street consensus, reassured anxious investors that MHS's NT fundamentals remain solid. Mgmt's comments about the sizable 2012 generic opportunity and its 10-yr perspective also underscored MHS's robust growth profile and the stock's compelling valuation."
Shares of MHS gained $5.63 yesterday to close at $58, a gain of over 10%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in